-
1Academic Journal
المؤلفون: Rodrigo Pinheiro Araldi, Benedito Carlos Prezoto, Vivian Gonzaga, Bruna Policiquio, Thais Biude Mendes, Fernanda D’Amélio, Hugo Vigerelli, Mariana Viana, Cristiane Wenceslau Valverde, Eduardo Pagani, Irina Kerkis
المصدر: Biomedicine & Pharmacotherapy, Vol 149, Iss , Pp 112920- (2022)
مصطلحات موضوعية: HIDPSC, TF/CD142, Procoagulant potential, Safety, COVID-19, MSC, Therapeutics. Pharmacology, RM1-950
Relation: http://www.sciencedirect.com/science/article/pii/S0753332222003092; https://doaj.org/toc/0753-3322; https://doaj.org/article/d8710a474ce049c39b71e96c709f3797
-
2Academic Journal
المؤلفون: Pereira Portela, C., Stirnimann, G., Kröll, D., Aliotta, A., Veuthey, L., Zermatten, M.G., Alberio, L., Bertaggia Calderara, D.
المصدر: Thrombosis research, vol. 237, pp. 34-36
مصطلحات موضوعية: Rivaroxaban/pharmacology, Rivaroxaban/therapeutic use, Humans, Anticoagulants/pharmacology, Anticoagulants/therapeutic use, Factor Xa Inhibitors/pharmacology, Factor Xa Inhibitors/therapeutic use, Blood Coagulation/drug effects, Male, Bariatric surgery, DOAC, Procoagulant potential, Rivaroxaban, Thrombin generation
Relation: info:eu-repo/semantics/altIdentifier/pmid/38547692; info:eu-repo/semantics/altIdentifier/eissn/1879-2472; https://serval.unil.ch/notice/serval:BIB_DED47B693956